Patient Leaflet Updated 09-Oct-2024 | Wockhardt UK Ltd
Metaraminol 10mg/ml Solution for Injection or Infusion
Metaraminol 10mg/ml Solution for Injection or Infusion
Metaraminol Tartrate
This includes any possible side effects not listed in this leaflet. See section 4.
1. What Metaraminol is and what it is used for
2. What you need to know before you use Metaraminol
3. How to use Metaraminol
4. Possible side effects
5. How to store Metaraminol
6. Contents of the pack and other information
The active substance Metaraminol Tartrate belongs to a group of medicines called vasopressors which work by narrowing the blood vessels causing blood pressure to rise.
It is used to raise low blood pressure to normal levels in an emergency situation.
You will be given this medicine in hospital by a doctor or nurse.
Talk to your doctor, nurse or pharmacist before using metaraminol if you have:
This medicine is not recommended for use in children below the age of 12 years.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. It is especially important if you are taking:
The effects of this medicine on the unborn baby is unknown. It is not known whether this medicine is present in breast milk. You will only be given this medicine if your doctor sees the clinical need to do so in an emergency situation.
Sodium metabisulfite - a preservative which may rarely cause severe hypersensitivity reactions and bronchospasm. It may also cause skin reactions if spilt on the skin.
Sodium - contains less than 1mmol sodium (23mg) per 10mg/ml ampoule, that is to say essentially 'sodium - free'.
A nurse or doctor will give you this medicine.
In the case of an emergency, this medicine is given by direct injection into a vein, which may be followed by an infusion into a vein. The dose will be adjusted by your doctor.
The usual dose is between 0.5 - 5mg injected into the vein, followed by an infusion of 15 - 100mg in 500ml Sodium Chloride Injection or Glucose 5% Injection.
Metaraminol 10mg/ml Solution for Injection or Infusion may be used undiluted or diluted.
It is unlikely that you will receive too much because this medicine will be given to you in hospital. You will be carefully monitored by your doctor for symptoms or severely high blood pressure (see symptoms in Section 4 Possible Side Effects).
If you have any further questions on the use of this medicine, ask your doctor or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the label and carton as EXP.
The expiry date refers to the last day of that month. Before use, the doctor or nurse will check the medicine has not passed this date and that the medicine does not show any sign of deterioration.
Do not throw away any medicines via wastewater. These measures will help protect the environment.
Only use this medicine if it is particle free. This medicine is for single use only.
Store below 25°C.
If diluted in a sterile environment, the medicine can be stored for up to 48 hours at ambient temperature 20-22°C or between 2 to 8°C.
The active substance is metaraminol tartrate (1.9 %w/v), which is equivalent to 1.0 %w/v (10mg/ml) metaraminol.
The other ingredients are: sodium chloride, sodium metabisulfite (E223) and water for injections.
May contain traces of sodium hydroxide or hydrochloric acid (for pH adjustment).
This medicine is a clear, colourless solution free of particles.
It is available in a 1 ml clear glass ampoules with a purple coloured spot and one-point-cut score, packed into cartons containing 10 ampoules.
Other formats
To listen to or request a copy of this leaflet in Braille, large print or audio please call, free of charge: 0800 198 5000 (UK only). Please be ready to give the following information:
Product name Reference number
Metaraminol 10mg/ml Solution for Injection or Infusion PL 29831/0740
This is a service provided by the Royal National Institute of Blind People.
This leaflet was last revised in 03/2024
108609/2
Ash Road North, Wrexham Industrial Estate, Wrexham, LL13 9UF
+44 (0)1978 661 702
+44 (0)1978 661 261
www.wockhardt.co.uk